Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Teva Pharmaceutical to Replace CEO Kare Schultz

Teva Pharmaceutical to Replace CEO Kare Schultz

-Wall Street Journal

byCharles Gross

November 3, 2022

1 minute read

-Wall Street Journal

Bitcoin Network Tops $100 Trillion In Total Transacted Value: Ark Analyst Urges Caution On ‘Landmark’

By Samyuktha Sriram

August 26, 2:12 AM

Bitcoin (CRYPTO: BTC) has seen over $100 trillion in total value transferred over its blockchain since it was first created.

BTC

NewAmsterdam Pharma Announces Appointment Of Ian Somaiya As Chief Financial Officer

By Happy Mohamed

October 23, 8:11 AM

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of cardiovascular disease with residual elevation of low-density

NAMS

What’s Going On With Virgin Galactic Stock Today?

By Adam Eckert

May 8, 11:06 AM

Virgin Galactic Holdings Inc (NYSE: SPCE) shares are taking off Monday.

SPCE

Goldman Sachs Maintains Buy on EOG Resources, Raises Price Target to $143

By Benzinga Newsdesk

October 19, 11:00 AM

Goldman Sachs analyst Neil Mehta maintains EOG Resources (NYSE:EOG) with a Buy and raises the price target from $125 to $143.

EOG

Teva Pharmaceutical to Replace CEO Kare Schultz

Related Posts

Bitcoin Network Tops $100 Trillion In Total Transacted Value: Ark Analyst Urges Caution On ‘Landmark’

NewAmsterdam Pharma Announces Appointment Of Ian Somaiya As Chief Financial Officer

What’s Going On With Virgin Galactic Stock Today?

Goldman Sachs Maintains Buy on EOG Resources, Raises Price Target to $143